We also observed a higher frequency of neutrophils within immune cells isolated from leukemia-infiltrated spleens of AML-bearing mice upon anti–TIM-3 Ab treatment, consistent with several recent independent studies showing that neutrophils may contribute to tumor control (36, 37). The gene discussed is HAVCR2; the disease is leukemia.